Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy.
about
Vascular endothelial growth factor as an anti-angiogenic target for cancer therapyPreclinical molecular imaging of tumor angiogenesis.Multispectral fluorescence ultramicroscopy: three-dimensional visualization and automatic quantification of tumor morphology, drug penetration, and antiangiogenic treatment responseIn vivo spectral and fluorescence microscopy comparison of microvascular function after treatment with OXi4503, Sunitinib and their combination in Caki-2 tumors.Delivery of antiangiogenic agents for cancer gene therapy.Antiangiogenic cancer therapies get their act together: current developments and future prospects of growth factor- and growth factor receptor-targeted approaches.The role of nitric oxide in mediating tumour blood flow.Bevacizumab in combination with IFN-α in metastatic renal cell carcinoma: the AVOREN trial.Advances and new perspectives in the treatment of metastatic colon cancer.Metronomic chemotherapy in combination with antiangiogenic treatment induces mosaic vascular reduction and tumor growth inhibition in hepatocellular carcinoma xenografts.Differential distribution of blood-derived proteins in xenografted human adenocarcinoma tissues by in vivo cryotechnique and cryobiopsy.Monitoring the longitudinal intra-tumor physiological impulse response to VEGFR2 blockade in breast tumors using DCE-CT.Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.Pharmacokinetic Considerations for Antibody-Drug Conjugates against Cancer.
P2860
Q30455612-34C307A3-9E47-4429-AFA1-A55A20E5D2D0Q30475818-67E63E42-4C90-4C3A-9B9E-6E721E3183CEQ30571893-EA789BAF-4D05-4D52-AD82-14BF73BFE7A8Q33738607-98C2941F-061F-42F0-9869-86B82E631422Q36200143-58D02273-9A45-440E-B710-95BEC8E580B6Q36397316-CD9BE62C-CEF9-4B59-A9DB-5BB13D1646BCQ36596676-077E6E1A-4F85-4AD0-A56E-14008AD0865AQ38058530-2C6D60B8-FE4C-4A05-A43C-40CF00B54EBDQ38229589-AA712E40-2D6A-4F00-9F23-5CFE8F19B2E1Q39324636-34EEB9BE-806D-4996-BB23-F61BEAE4A996Q39515605-DF183439-39FB-42C1-A72B-B69935A8C61AQ39642439-F98550F8-2B1C-47F7-87D0-9C0BDE2D1A0EQ44569073-74E946F1-F5A7-4099-90BF-4452FFADBD71Q47661007-1EEE4968-D6AF-4D64-9F92-B001FEE31A4D
P2860
Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Improving delivery of antineop ...... thelial growth factor therapy.
@ast
Improving delivery of antineop ...... thelial growth factor therapy.
@en
type
label
Improving delivery of antineop ...... thelial growth factor therapy.
@ast
Improving delivery of antineop ...... thelial growth factor therapy.
@en
prefLabel
Improving delivery of antineop ...... thelial growth factor therapy.
@ast
Improving delivery of antineop ...... thelial growth factor therapy.
@en
P2093
P2860
P356
P1433
P1476
Improving delivery of antineop ...... thelial growth factor therapy.
@en
P2093
Anthony D Yang
E Ramsay Camp
Lee M Ellis
Ray Somcio
Todd W Bauer
Wenbiao Liu
P2860
P304
P356
10.1002/CNCR.20942
P407
P577
2005-04-01T00:00:00Z